New insight into the hypercoagulability of Cushing's syndrome

Neuroendocrinology

Volumn 93, Issue 2, 2011, Pages 121-125

  Daidone, Viviana ^a   Boscaro, Marco ^b   Pontara, Elena ^a   Cattini, Maria Grazia ^a   Occhi, Gianluca ^a   Scaroni, Carla ^a   Mantero, Franco ^a   Casonato, Alessandra ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Cushing's syndrome; Hypercoagulable state of Cushing's syndrome; Von Willebrand factor; Von Willebrand factor promoter (GT)n; Von Willebrand factor promoter single nucleotide polymorphisms

Indexed keywords

HYDROCORTISONE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CUSHING SYNDROME; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; HAPLOTYPE; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; UPREGULATION;

ADULT; CUSHING SYNDROME; FEMALE; HAPLOTYPES; HUMANS; HYDROCORTISONE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; THROMBOPHILIA; VON WILLEBRAND FACTOR;

EID: 79952573624     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323765     Document Type: Article

References (18)

1. Boscaro M, Barzon L, Fallo F, Sonino N: Cushing's syndrome. Lancet 2001; 357: 783-791. (Pubitemid 32217692)
2. Etxabe J, Vazquez JA: Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol 1994; 40: 479-484. (Pubitemid 24194645)
3. Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MT, Fliers E, Gerdes VE, Büller HR, Brandjes DP: Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab 2009; 94: 2743-2750.
4. Dal Bo Zanon R, Fornasiero L, Boscaro M, Ruffato G, Luzzato G, Fabris F, Girolami A: Clotting changes in Cushing's syndrome: elevated factor VIII activity. Folia Haematol 1983; 110: 268-277.
5. Patrassi GM, Dal Bo Zanon R, Boscaro M, Martinelli S, Girolami A: Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thromb Haemost 1985; 54: 518-520. (Pubitemid 16255686)
6. Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM: Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J Endocrinol Invest 2000; 23: 145-150. (Pubitemid 30218782)
7. Ruggeri ZM: Von Willebrand factor. Curr Opin Hematol 2003; 10: 142-149.
8. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR: The effect of ABO blood group in the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-1695. (Pubitemid 17091627)
9. Casonato A, Daidone V, Sartorello F, Albiger N, Romualdi C, Mantero F, Pagnan A, Scaroni C: Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome. Br J Haematol 2008; 140: 230-235. (Pubitemid 350265047)
10. Keightley AM, Lam YM, Brady JN, Cameron CL, Lillicrap D: Variation at the von Willebrand factor (VWF) gene locus is associated with plasma VWF levels: identification of three novel single nucleotide polymorphisms in the VWF gene promoter. Blood 1999; 93: 4277-4283. (Pubitemid 29279270)
11. Harvey PJ, Keightley AM, Lam YM, Cameron C, Lillicrap D: A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels. Br J Haematol 2000; 109: 349-353. (Pubitemid 30350716)
12. n repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions. Thromb Haemost 2009; 101: 298-304.
13. Hough C, Cameron CL, Notley CR, Brown C, O'Brien L, Keightley AM, Berber E, Lillicrap D: Influence of a GT repeat element on shear stress responsiveness of the VWF gene promoter. J Thromb Haemost 2008; 6: 1183-1190. (Pubitemid 351859129)
14. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M: Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003; 88: 5593-5602. (Pubitemid 38033020)
15. Casonato A, Pontara E, Sartorello F, Cattini MG, Sartori MT, Padrini R, Girolami A: Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. Blood 2002; 99: 180-184.
16. Casonato A, Pontara E, Boscaro M, Sonino N, Sartorello F, Ferasin S, Girolami A: Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood Coagul Fibrinolysis 1999; 10: 145-151. (Pubitemid 29225577)
17. Ou XM, Chen K, Shih JC: Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J Biol Chem 2006; 281: 21512-21525. (Pubitemid 44115488)
18. Hayashi R, Wada H, Ito K, Adcock IM: Effects of glucocorticoids on gene transcription. Eur J Pharmacol 2004; 500: 51-62. (Pubitemid 39303996)